Hello, Fool! | Login | Signup | My Fool
Oct 13, 2008 4:33 PM ET | Feedback | Site Changes | Help
A biotechnology company focused on the development and commercialization of novel biological therapies for patients with cancer.
View Ticker Page (CEGE)
Results 51 - 56 of 56 : « Previous 6
Recs
mjetsu (< 20) Submitted: 1/29/07 10:39 PM : Start Price: $3.14 CEGE Score: -51.01
Intuition :-)
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
SwissBioFreak (56.33) Submitted: 4/15/07 7:59 AM : Start Price: $5.30 CEGE Score: -56.88
Enrolling now patients for phase ii trials. If this is successfull the stock will soar.
TechnicalTommy (< 20) Submitted: 1/17/07 9:22 AM : Start Price: $3.25 CEGE Score: -51.39
$4 target
orangehat (97.70) Submitted: 4/02/08 12:25 AM : Start Price: $2.89 CEGE Score: -53.27
I own shares of CEGE.
dymwit (88.44) Submitted: 1/03/07 1:21 PM : Start Price: $3.38 CEGE Score: -52.12
takeover candidate?
Stampede1253 (< 20) Submitted: 8/14/08 7:52 PM : Start Price: $3.38 CEGE Score: -58.95
GVAX is on track with two phase III studies due to be released in second half of 2009. The Takeda deal only solidified a solid platform for GVAX and the desired endpoint of extended life.
Terms & Conditions
RSS Headlines
Fool UK